KR100285396B1 - A composite powder, a method for preparing of the same and make-up cosmetics containing the same - Google Patents
A composite powder, a method for preparing of the same and make-up cosmetics containing the same Download PDFInfo
- Publication number
- KR100285396B1 KR100285396B1 KR1019990010994A KR19990010994A KR100285396B1 KR 100285396 B1 KR100285396 B1 KR 100285396B1 KR 1019990010994 A KR1019990010994 A KR 1019990010994A KR 19990010994 A KR19990010994 A KR 19990010994A KR 100285396 B1 KR100285396 B1 KR 100285396B1
- Authority
- KR
- South Korea
- Prior art keywords
- hydrolyzed collagen
- collagen
- polyglyceryl
- sodium
- skin
- Prior art date
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 55
- 239000000843 powder Substances 0.000 title claims abstract description 38
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 152
- 102000008186 Collagen Human genes 0.000 claims abstract description 152
- 229920001436 collagen Polymers 0.000 claims abstract description 152
- 239000000049 pigment Substances 0.000 claims abstract description 73
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 claims abstract description 25
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 24
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 23
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920001222 biopolymer Polymers 0.000 claims abstract description 17
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 31
- 239000011734 sodium Substances 0.000 claims description 28
- 229910052708 sodium Inorganic materials 0.000 claims description 28
- -1 dimethylaminohydroxypropyl Chemical group 0.000 claims description 25
- 239000011591 potassium Substances 0.000 claims description 17
- 229910052700 potassium Inorganic materials 0.000 claims description 17
- 239000011787 zinc oxide Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- 108010045569 atelocollagen Proteins 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 6
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims description 6
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 6
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 6
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 229940070765 laurate Drugs 0.000 claims description 6
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 4
- 229920002101 Chitin Polymers 0.000 claims description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 4
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 3
- 125000005399 allylmethacrylate group Chemical group 0.000 claims description 3
- 229940014041 hyaluronate Drugs 0.000 claims description 3
- 229940049964 oleate Drugs 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 claims description 2
- UCWYGNTYSWIDSW-QXMHVHEDSA-N (z)-n-[3-(dimethylamino)propyl]octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCCN(C)C UCWYGNTYSWIDSW-QXMHVHEDSA-N 0.000 claims description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 2
- 229940051593 dermatan sulfate Drugs 0.000 claims description 2
- 229940062933 dimethylsilanol hyaluronate Drugs 0.000 claims description 2
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- LWIGVRDDANOFTD-UHFFFAOYSA-N hydroxy(dimethyl)silane Chemical compound C[SiH](C)O LWIGVRDDANOFTD-UHFFFAOYSA-N 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 2
- 229940043707 polyglyceryl-6 distearate Drugs 0.000 claims description 2
- 229940104257 polyglyceryl-6-dioleate Drugs 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical class 0.000 claims description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 239000004816 latex Substances 0.000 claims 2
- 229920000126 latex Polymers 0.000 claims 2
- 240000006890 Erythroxylum coca Species 0.000 claims 1
- 108010050808 Procollagen Proteins 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 235000008957 cocaer Nutrition 0.000 claims 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 125000001033 ether group Chemical group 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229920000223 polyglycerol Polymers 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 12
- 230000000903 blocking effect Effects 0.000 abstract description 9
- 230000007547 defect Effects 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 239000012463 white pigment Substances 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 68
- 239000000499 gel Substances 0.000 description 41
- 238000002360 preparation method Methods 0.000 description 36
- 238000009472 formulation Methods 0.000 description 26
- 239000003921 oil Substances 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- NZXGQSGKXLTAIH-UHFFFAOYSA-N dimethoxy(oxo)silane Chemical compound CO[Si](=O)OC NZXGQSGKXLTAIH-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000007786 electrostatic charging Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940114926 stearate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- GTEXIOINCJRBIO-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-n,n-dimethylethanamine Chemical compound CN(C)CCOCCN(C)C GTEXIOINCJRBIO-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004669 Protein-Lysine 6-Oxidase Human genes 0.000 description 1
- 108010003894 Protein-Lysine 6-Oxidase Proteins 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- ATYGMDZIBQHJFX-UHFFFAOYSA-N imidazolidine;urea Chemical compound NC(N)=O.C1CNCN1 ATYGMDZIBQHJFX-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C3/00—Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
- C09C3/10—Treatment with macromolecular organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
Abstract
본 발명은 콜라겐 또는 콜라겐과 보습 바이오폴리머를 함유하는 무수 소수성 겔을 흡유력이 뛰어난 다공성의 알릴메타크릴레이트 가교중합체 파우다에 함입시키거나, 무수 소수성 겔이 함입된 알릴메타크릴레이트 가교중합체 파우더의 표면에 자외선 차단 백색 안료를 더 부착시킴으로써, 피부의 결점이나 주름을 은폐시킬 수 있고, 피부의 수분을 균형있게 유지시킬 수 있으며, 자외선을 차단하여 피부를 보호할 수 있는 복합안료, 이의 제조방법 및 이를 함유하는 화장료에 관한 것이다.The present invention incorporates anhydrous hydrophobic gel containing collagen or collagen and a moisturizing biopolymer into a porous allyl methacrylate crosspolymer powder having excellent oil absorption, or the surface of an allyl methacrylate crosspolymer powder containing anhydrous hydrophobic gel. By further attaching a UV-blocking white pigment on the skin, it is possible to cover up the defects and wrinkles of the skin, to maintain the moisture of the skin in a balanced manner, a composite pigment that can protect the skin by blocking ultraviolet rays, a method of manufacturing the same and the same It relates to cosmetics to contain.
Description
본 발명은 콜라겐 또는 콜라겐과 보습 바이오폴리머를 함유하는 무수 소수성 겔을 흡유력이 뛰어난 다공성의 알릴메타크릴레이트 가교중합체 파우다에 함입시키거나, 무수 소수성 겔이 함입된 알릴메타크릴레이트 가교중합체 파우더의 표면에 자외선 차단 백색 안료를 더 부착시킴으로써, 피부의 결점이나 주름을 은폐시킬 수 있고, 피부의 수분을 균형있게 유지시킬 수 있으며, 자외선을 차단하여 피부를 보호할 수 있는 복합안료, 이의 제조방법 및 이를 함유하는 화장료에 관한 것이다.The present invention incorporates anhydrous hydrophobic gel containing collagen or collagen and a moisturizing biopolymer into a porous allyl methacrylate crosspolymer powder having excellent oil absorption, or the surface of an allyl methacrylate crosspolymer powder containing anhydrous hydrophobic gel. By further attaching a UV-blocking white pigment on the skin, it is possible to cover up the defects and wrinkles of the skin, to maintain the moisture of the skin in a balanced manner, a composite pigment that can protect the skin by blocking ultraviolet rays, a method of manufacturing the same and the same It relates to cosmetics to contain.
일반적으로 피부의 노화는 나이가 들어감에 따라 필연적으로 발생되는 내인성 노화(Intrinsic aging)와 광노화(Actinic aging)가 합쳐져서 일어나는 것으로, 피부의 탄력성과 신축성의 저하로 주름이 형성되고, 피부 근력의 저하로 피부의 늘어짐이 생기며, 멜라닌 색소 침착과 피부색의 수분량 저하에 의해 투명감 감소 등과 같은 현상이 생긴다.Generally, aging of the skin is caused by the combination of endogenous aging and photoaging, which are inevitable with age, and wrinkles are formed due to the decrease of elasticity and elasticity of the skin. Skin sagging occurs, and phenomena such as decrease in clarity are caused by melanin pigmentation and decrease in moisture content of the skin color.
이러한 피부노화 현상, 특히 피부가 이완되고 주름살이 생기는 주된 원인은콜라겐 섬유와 탄성 섬유의 변화때문이다.The main cause of skin aging, especially skin relaxation and wrinkles, is the change in collagen fibers and elastic fibers.
즉, 콜라겐은 몸에서 가장 풍부한 단백질로 신체내에서 몸의 체형을 유지해 주고 보호해 주는 물리적인 역할을 하는 것으로서, 정상적인 몸에서는 콜라겐의 합성과 분해가 정확하게 조절되어 균형이 유지되지만, 노화된 피부에서는 활성 산소등에 의한 세포 활동의 저하로 콜라겐 생성의 저하를 가져오고 리실옥시다제(Lysyl oxidase)라는 산소의 작용으로 콜라겐 조직사이에 필요이상의 가교가 형성되어 조직이 단단해지며, 콜라겐 섬유의 변성으로 탄력성을 잃게 되는 것이다.In other words, collagen is the most abundant protein in the body and plays a physical role in maintaining and protecting the body's body shape in the body. In the normal body, the synthesis and decomposition of collagen are precisely controlled and balanced, but in aged skin Decreased collagen production by deactivation of cellular activity by active oxygen, etc. The action of oxygen called Lysyl oxidase, which creates more crosslinks between collagen tissues and makes the tissue harder. It is lost.
따라서, 종래에는 이러한 피부노화에 따른 콜라겐의 감소를 보충하기 위해서, 콜라겐 또는 콜라겐과 엘라스틴 등의 조직사이에 존재하는 기질의 주성분으로서 물을 함유하는 보수성이 뛰어난 글리코사미노글리칸(Glycosaminoglycan)을 화장료에 배합하여 왔다(USP 4,228,153). 그러나, 이러한 노화방지 화장료는 대부분이 콜라겐 수용액이나 글리코사미노글리칸의 일종인 히아루론산 수용액을 단순히 혼합시킨 것으로, 대부분이 스킨 케어제품이다. 즉, 콜라겐과 글리코사미노글리칸은 스킨케어제품에서 단순히 가용성 담체나 가용성분의 형태로 사용될 뿐, 파우더나 색조안료가 주요부분을 차지하는 메이크업 제품에서는 그 사용이 제한되는 문제점이 있었다.Therefore, conventionally, in order to compensate for the reduction of collagen due to skin aging, glycosaminoglycan having excellent water retention as a main component of a collagen or a substrate existing between tissues such as collagen and elastin is used as a cosmetic. It has been formulated in (USP 4,228,153). However, most of these anti-aging cosmetics are simply a mixture of an aqueous collagen solution or an aqueous solution of hyaluronic acid, which is a kind of glycosaminoglycan, and most of them are skin care products. That is, collagen and glycosaminoglycan are simply used in the form of a soluble carrier or a soluble component in skin care products, and there is a problem that its use is limited in makeup products in which powders or color pigments occupy the main part.
또한, 콜라겐을 한국특허공개공보 제 96-6911호에서와 같이 유효활성성분을 그 안에 포함시킨 캡슐의 피막재로 사용하기도 하였으나, 이것도 캡슐을 용액상에 분산시킨 것이므로, 파우더 제품의 경우 제형의 특성을 나타내기 어려운 문제점이 있었다. 또한, 한국특허공고공보 제 96-4695호에서와 같이 히아루론산을 효모다당체 분말의 내부와 표면에 있는 구멍에 함입시킨 안료를 색조화장료에 함유시킴으로써 피부에의 보습성을 향상시킨 것이 개시되어 있으나, 이것은 색조안료로서의 기능이 미흡하였다.In addition, collagen was used as a coating material of the capsule containing the active ingredient therein as in Korean Patent Publication No. 96-6911, but this is also because the capsule is dispersed in a solution, the characteristics of the formulation of powder products There was a problem that is difficult to represent. In addition, as disclosed in Korean Patent Publication No. 96-4695, it has been disclosed to improve the moisturization to the skin by incorporating a pigment containing hyaluronic acid into the pores in the inside and the surface of the yeast polysaccharide powder in the color cosmetic. The function as a color pigment was insufficient.
이에, 본 발명자들은 콜라겐을 파우더나 색조안료가 중요한 부분을 차지하는 메이크업 제품에 함유시켰을 때 발생하는 상기한 문제점을 해결하기 위해서 연구를 거듭한 결과, 콜라겐을 무수 소수성 겔속에서 안정화시킨 다음, 이를 알릴메타크릴레이트 가교중합체 파우더에 함입시킨 복합안료는 메이크업 제품에서 안정하게 사용될 수 있고, 콜라겐 자체의 보습력에 의해서 피부의 수분이 유지되어 피부와 화장막의 갈라짐을 방지할 수 있으며, 더구나 피부의 주름을 은폐시킬 수 있다는 것을 발견하고 본 발명을 완성하게 되었다. 또한, 무수 콜라겐을 함유하는 무수 소수성 겔에 보습효과를 갖는 물질로 공지된 바이오폴리머를 더 함유시킨 복합안료는 상기한 효과가 더욱 상승될 수 있다는 것을 발견하였다.Accordingly, the present inventors have repeatedly studied to solve the above problems that occur when the collagen is contained in a makeup product in which powder or color pigments are an important part, and as a result, the collagen is stabilized in anhydrous hydrophobic gel, and then allyl meta Composite pigments embedded in acrylate cross-linked polymer powder can be used stably in make-up products, and the moisture of the collagen itself keeps the moisture of the skin and prevents the splitting of the skin and the makeup film. It has been found that the present invention has been completed. In addition, it has been found that the composite pigment which further contains a biopolymer known as a moisturizing substance in the anhydrous hydrophobic gel containing anhydrous collagen may further enhance the above-mentioned effect.
또한, 자외선 차단 효과가 있는 백색안료, 즉 초미립자 산화아연을 정전기적 대전 현상으로 상기 복합안료의 표면에 부착시킨 복합안료는 상기한 효과 이외에도 자외선을 차단하여 피부를 보호해 줄 수 있고, 뭉침현상없이 제형내에 고르게 분포할 수 있으며, 자신의 피부색을 자연스럽게 표현해주면서 결점을 가려줄 수 있는 피부보정능력이 우수하다는 것을 발견하였다.In addition, the white pigment having a UV blocking effect, that is, the composite pigment attached to the surface of the composite pigment by the ultrafine zinc oxide oxide electrostatic charging phenomenon can protect the skin by blocking ultraviolet rays in addition to the above-described effect, without agglomeration phenomenon It has been found to be evenly distributed in the formulation, and has excellent skin correction ability to mask the defects while naturally expressing the color of the skin.
따라서, 본 발명의 목적은 피부의 수분을 유지할 수 있고, 피부의 결점을 커버할 수 있으며, 자외선을 효과적으로 차단할 수 있는 복합안료를 제공하는 것이다.Accordingly, an object of the present invention is to provide a composite pigment that can maintain the moisture of the skin, cover the defects of the skin, and can effectively block ultraviolet rays.
또한, 본 발명의 다른 목적은 상기한 복합안료의 제조방법을 제공하는 것이다.In addition, another object of the present invention is to provide a method for producing a composite pigment.
또한, 본 발명의 또 다른 목적은 상기한 복합안료를 함유하는 화장료를 제공하는 것이다.In addition, another object of the present invention is to provide a cosmetic containing the above composite pigment.
도 1은 본 발명의 복합안료의 UV/Vis 스펙트럼이다.1 is a UV / Vis spectrum of the composite pigment of the present invention.
상기한 목적을 달성하기 위해서, 본 발명에 따른 복합안료는 콜라겐을 함유하는 무수 소수성 겔(dehydrated hydrophobic gel)을 알릴메타크릴레이트 가교중합체 파우더에 함입시킴을 특징으로 한다.In order to achieve the above object, the composite pigment according to the present invention is characterized by incorporating a collagen-containing dehydrated hydrophobic gel into the allyl methacrylate crosspolymer powder.
또한, 본 발명의 복합안료는 상기 무수 소수성 겔에 보습 바이오폴리머를 더 함유시킴을 특징으로 한다.In addition, the composite pigment of the present invention is characterized in that it further contains a moisturizing biopolymer in the anhydrous hydrophobic gel.
또한, 본 발명의 복합안료는 상기 무수 소수성 겔이 함입된 상기 알릴메타크릴레이트 가교중합체 파우더의 표면에 초미립자 산화아연을 더 부착시킴을 특징으로 한다.In addition, the composite pigment of the present invention is characterized by further attaching ultrafine zinc oxide to the surface of the allyl methacrylate crosspolymer powder containing the anhydrous hydrophobic gel.
또한, 본 발명의 복합안료의 제조방법은 콜라겐 또는 콜라겐과 보습 바이오폴리머를 오일에 분산시킨 후, 건조하여 무수 소수성 겔을 제조하는 단계 및 무수 소수성 겔을 알릴메타크릴레이트 가교중합체와 혼합하는 단계를 포함함을 특징으로 한다.In addition, the method of preparing a composite pigment of the present invention comprises the steps of dispersing collagen or collagen and a moisturizing biopolymer in an oil, followed by drying to prepare anhydrous hydrophobic gel and mixing the anhydrous hydrophobic gel with allyl methacrylate crosspolymer. It is characterized by including.
또한, 본 발명에 따른 화장료는 상기한 복합안료를 조성물 총 중량에 대하여 0.05∼70.0중량%의 양으로 함유함을 특징으로 한다.In addition, the cosmetic composition according to the invention is characterized in that it contains the composite pigment in an amount of 0.05 to 70.0% by weight based on the total weight of the composition.
이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 복합안료는 기존의 다공성 분말보다 오일 흡유력이 10배나 뛰어나고, 가벼우며, 액체상 뿐만 아니라 고체상도 동시에 내포할 수 있는 알릴메타크릴레이트 가교중합체(Allyl methacrylates crosspolymer) 파우다에 피부의 지지 물질이면서 보습 물질인 콜라겐을 탈수된 상태로 함입시킨 후, 피부 수분에 의한 팽윤 현상으로 부피 팽창하도록 하여 피부 요철을 채워줌으로써 피부 주름을 은폐시키고 동시에 콜라겐 자체의 보습력에 의해서 피부의 당김 현상 없이 수분을 유지시켜 피부 및 화장막의 갈라짐을 막아줄 수 있다. 더구나, 상기 무수 소수성 겔에 보습 바이오폴리머를 더 함유시킨 본 발명의 복합안료는 상기한 효과들이 더욱 상승될 수 있다. 또한, 광노화의 근본적인 대책으로서 자외선 차단제인 초미립자 산화아연을 분산력이 뛰어난 알릴메타크릴레이트 파우다에 정전기적 대전 현상으로 부착시킴으로서 백색 안료에서 흔히 나타나는 뭉침 현상 없이 난반사에 의한 소프트-포커싱(Soft-Focusing) 효과로 자연스런 커버력을 제공할 수 있으며, 피부를 보호할 수 있다.The composite pigment of the present invention is 10 times better in oil absorption than conventional porous powders, and is a support material for skin in allyl methacrylates crosspolymer powder which can contain both liquid and solid phases simultaneously. After incorporating collagen, a moisturizing substance, in a dehydrated state, it swells in volume due to swelling caused by skin moisture to fill skin irregularities, thereby concealing wrinkles and maintaining moisture without pulling the skin by the moisturizing power of collagen itself. Can prevent skin and cremation cracking. Moreover, the composite pigment of the present invention further containing a moisturizing biopolymer in the anhydrous hydrophobic gel may further enhance the above effects. In addition, as a fundamental countermeasure against photoaging, ultrafine zinc oxide, a sunscreen agent, is attached to an allyl methacrylate powder having excellent dispersibility as an electrostatic charging phenomenon, thereby soft-focusing effect due to diffuse reflection without the aggregation phenomenon commonly found in white pigments. It can provide natural coverage and protect skin.
본 발명의 복합안료는 먼저 콜라겐이 수분과 접촉하여 팽창되는 것을 막기 위하여 콜라겐을 무수 소수성 겔에 함유시킨다. 즉, 콜라겐 자체의 영향으로 피부에 탄력을 주고, 수분의 증발을 막아 건조로 인한 피부와 화장막의 갈라짐이 생기는 것을 막아주는 보습제로서의 역할뿐만 아니라 콜라겐이 피부 표면 주름의 요철 사이에 존재하다가 피부의 수분과 접촉하게 되면 점차로 팽윤되어 피부 주름의 요철을 채우는 필링재로서의 역할도 하여 피부의 주름을 은폐하기 위하여, 콜라겐을 무수 소수성 겔에 함유시킨다.The composite pigment of the present invention first contains collagen in anhydrous hydrophobic gel to prevent the collagen from expanding in contact with water. In other words, the collagen itself acts as a moisturizer that gives elasticity to the skin and prevents evaporation of moisture and prevents cracking of the skin and the cosmetic film due to drying, as well as collagen is present between the irregularities of the skin surface wrinkles. When it comes in contact with swelling gradually serves as a filling material to fill the irregularities of the skin wrinkles, collagen is contained in the anhydrous hydrophobic gel to cover the wrinkles of the skin.
콜라겐을 무수 소수성 겔에 함유시키는 방법은 콜라겐을 오일에 고속분산시킨 후, 탈수·건조시켜 제조하거나, 탈수된 고형상의 콜라겐을 1∼5㎛로 미분쇄한 후, 오일에 분산, 건조시켜 함유시킨다.The method of incorporating collagen into anhydrous hydrophobic gel is prepared by dispersing collagen in oil at high speed followed by dehydration and drying, or by pulverizing dehydrated solid collagen at 1 to 5 µm, and then dispersing and drying in oil. Let's do it.
본 발명의 복합안료는 상기한 방법으로 무수 소수성 겔에 콜라겐을 함유시킨 다음, 이 무수 소수성 겔을 다공성 알릴메타크릴레이트 가교중합체 파우더에 함입시킨다. 이는 무수 콜라겐이 함유된 무수 소수성 겔을 안정화시키고, 방출시간(releasing time)을 주어 겔속에 함유된 콜라겐이 서서히 자연스럽게 작용할 수 있도록 하기 위한 것이다. 즉, 다공성 알릴메타크릴레이트 가교중합체 파우더는 가볍고 퍼짐성이 우수한 반구형 형태의 중합체로서 친수성(Hydrophilic)이면서도 친유성(Lipophilic)인 2중 흡수 기능을 지니고 있어서 g당 각기 10g의 오일과 8g의 수분을 흡수할 수 있는 높은 흡수능을 지니고 있고, 액체상과 고체상을 동시에 함입할 수 있으며, 함입된 물질은 물리적인 힘이나 온도 상승, 단순한 확산에 의해서 배출될 수 있으므로, 무수 소수성 겔과 알릴메타크릴레이트 파우더를 단순히 혼합하는 것에 의해 파우더에 겔을 함입시킨다.The composite pigment of the present invention contains the collagen in the anhydrous hydrophobic gel by the above-described method, and then incorporates the anhydrous hydrophobic gel into the porous allylmethacrylate crosspolymer powder. This is to stabilize the anhydrous hydrophobic gel containing anhydrous collagen and to give a release time (releasing time) so that the collagen contained in the gel can work slowly and naturally. In other words, the porous allyl methacrylate crosslinked polymer powder is a hemispherical polymer having excellent lightness and spreading properties. It has a double absorption function that is hydrophilic and lipophilic, and thus absorbs 10g of oil and 8g of water per gram. It has a high absorption capacity and can contain both liquid and solid phases, and the impregnated material can be discharged by physical force, temperature rise, or simple diffusion, so that anhydrous hydrophobic gel and allyl methacrylate powder can be The gel is incorporated into the powder by mixing.
본 발명의 복합안료에서 콜라겐으로는 아텔로콜라겐, 알루미늄 카프릴로일 가수분해 콜라겐(Aluminum Capryloyl Hydrolyzed Collagen), 암모니움 가수분해 콜라겐, AMP-이소스테아로일(Isostearoyl) 가수분해 콜라겐, AMPD-이소스테아로일 가수분해 콜라겐, AMPD-로진 가수분해 콜라겐, 벤질리덴캄퍼(Benzylidenecamphor) 가수분해 콜라겐 술폰아마이드, 벤질트리모늄(Benzyltrimonium) 무수 콜라겐, 카프릴로일 가수분해 콜라겐, 코카미도프로필 디메틸아민 가수분해 콜라겐(Cocamidopropyl Dimethylamine Hydrolyzed Collagen), 코카미도프로필 디메틸아미노히드록시프로필 가수분해 콜라겐, 코카미도프로필디모니움 히드록시프로필 가수분해 콜라겐, 코코디모니움 히드록시프로필 가수분해 콜라겐, 코코일 가수분해 콜라겐, 데스아미도 콜라겐(Desamido Collagen), 가수분해 콜라겐 헥실데실 에스터(Hexyldecyl Ester of Hydrolyzed Collagen), 가수분해 콜라겐(Hydrolyzed Collagen), 히드록시프로필트리모니움 가수분해 콜라겐, 이소스테아로일 가수분해 콜라겐, 라우로일콜라겐 아미노산, 라우로일 가수분해 콜라겐, 라우로일디모니움 히드록시프로필 가수분해 콜라겐, MEA-가수분해 콜라겐, 미리스토일 가수분해 콜라겐, 올레아미도프로필 디메틸아민 가수분해 콜라겐, 올레아미도프로필디모니움(Oleamidopropyldimonium) 히드록시프로필 가수분해 콜라겐, 올레오일 가수분해 콜라겐, 팔미토일 가수분해 콜라겐, 포타슘 아비에토일 가수분해 콜라겐, 포타슘 코코일 가수분해 콜라겐, 포타슘 라우로일 가수분해 콜라겐, 포타슘 미리스토일 가수분해 콜라겐, 포타슘 올레오일 가수분해 콜라겐, 포타슘 스테아로일 가수분해 콜라겐, 포타슘 운데실레노일 가수분해 콜라겐, 프로콜라겐, 프로필트리모니움 가수분해 콜라겐, 쿼터늄-76 가수분해 콜라겐, 쿼터늄-79 가수분해 콜라겐, 소듐 라우로일 가수분해 콜라겐, 로진 가수분해 콜라겐, 소듐 코코일 가수분해 콜라겐, 소듐 미리스토일 가수분해 콜라겐, 소듐 올레오일 가수분해 콜라겐, 소듐 팔미토일 가수분해 콜라겐, 소듐 소이 가수분해 콜라겐, 소듐 스테아로일 가수분해 콜라겐, 스테아디모니움(Steardimonium) 히드록시프로필 가수분해 콜라겐, 스테아트리모니움 히드록시에틸 가수분해 콜라겐 또는 징크 가수분해 콜라겐으로부터 이루어진 군에서 선택된 1종 이상을 무수 소수성 겔 총 중량에 대하여 1∼20중량%의 양으로 사용할 수 있다.In the composite pigment of the present invention, as collagen, atelocollagen, aluminum capryloyl hydrolyzed collagen, ammonium hydrolyzed collagen, AMP-isostearoyl hydrolyzed collagen, AMPD-isostea Loyl Hydrolyzed Collagen, AMPD-Rosin Hydrolyzed Collagen, Benzylidenecamphor Hydrolyzed Collagen Sulfonamide, Benzyltrimonium Anhydrous Collagen, Capryloyl Hydrolyzed Collagen, Cocamidopropyl Dimethylamine Hydrolyzed Collagen ( Cocamidopropyl Dimethylamine Hydrolyzed Collagen), Cocamidopropyl Dimethylaminohydroxypropyl Hydrolyzed Collagen, Cocamidopropyldimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocoyl Hydrolyzed Collagen, Desami Desamido Collagen, hydrolyzed collagen hexyldecyl ester (Hex yldecyl ester of hydrolyzed collagen, hydrolyzed collagen, hydroxypropyltrimonium hydrolyzed collagen, isostearoyl hydrolyzed collagen, lauroyl collagen amino acid, lauroyl hydrolyzed collagen, lauroyldimony Um hydroxypropyl hydrolyzed collagen, MEA-hydrolyzed collagen, myristoyl hydrolyzed collagen, oleamidopropyl dimethylamine hydrolyzed collagen, oleamidopropyldimonium hydroxypropyl hydrolyzed collagen, oleyl Hydrolyzed collagen, palmitoyl hydrolyzed collagen, potassium avietoyl hydrolyzed collagen, potassium cocoyl hydrolyzed collagen, potassium lauroyl hydrolyzed collagen, potassium myristoyl hydrolyzed collagen, potassium oleoyl hydrolyzed collagen, potassium stearate Loyl Hydrolyzed Collagen, Potassium Undecylenoyl Hydrolyzed Collagen, Procoll Gen, Propyltrimonium Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Sodium Lauroyl Hydrolyzed Collagen, Rosin Hydrolyzed Collagen, Sodium Cocoy Hydrolyzed Collagen, Sodium Myristoyl Hydrolyzed Collagen, Sodium Oleoyl Hydrolyzed Collagen, Sodium Palmitoyl Hydrolyzed Collagen, Sodium Soy Hydrolyzed Collagen, Sodium Stearoyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Stearimoniium One or more selected from the group consisting of hydroxyethyl hydrolyzed collagen or zinc hydrolyzed collagen can be used in an amount of 1 to 20% by weight relative to the total weight of the anhydrous hydrophobic gel.
또한, 본 발명의 복합안료에서 콜라겐을 분산시키는 오일로는 폴리글리세릴-6 디올레이트, 에톡시디글리콜, 행인유(Apricot Kernel Oil) PEG-6 에스테르, 프로필렌글리콜 라우레이트, 실리카 디메릴 실리케이트, 폴리글리세릴-6 디팔미테이트, 폴리글리세릴-6 디스테아레이트, 폴리글리세릴-6 헥사올레이트, 폴리글리세릴-6 이소스테아레이트, 폴리글리세린-6 라우레이트, 폴리글리세릴-6 올레이트, 폴리글리세릴-6 팔미테이트, 폴리글리세릴-6 펜타올레이트, 폴리글리세릴-6 펜타리신올레이트, 폴리글리세릴-6 펜타스테아레이트, 폴리글리세릴-6 폴리리신올레이트, 폴리글리세릴-6 스테아레이트, 폴리글리세릴-6 테트라올레이트, 폴리글리세릴-6 트리스테아레이트, 폴리글리세릴-8 올레이트, 폴리글리세릴-8 스테아레이트 또는 PPG-8 폴리글리세릴-2 에테르로 이루어진 군에서 선택된 1종 이상을 무수 소수성 겔 총 중량에 대하여 80∼99중량%의 양으로 사용할 수 있다.In addition, as the oil dispersing collagen in the composite pigment of the present invention, polyglyceryl-6 dioleate, ethoxydiglycol, Apricot Kernel Oil PEG-6 ester, propylene glycol laurate, silica dimeryl silicate, poly Glyceryl-6 dipalmitate, polyglyceryl-6 distearate, polyglyceryl-6 hexaoleate, polyglyceryl-6 isostearate, polyglycerin-6 laurate, polyglyceryl-6 oleate, Polyglyceryl-6 Palmitate, Polyglyceryl-6 Pentaoleate, Polyglyceryl-6 Pentaricinolate, Polyglyceryl-6 Pentastearate, Polyglyceryl-6 Polylysinelate, Polyglyceryl- Consisting of 6 stearate, polyglyceryl-6 tetraoleate, polyglyceryl-6 tristearate, polyglyceryl-8 oleate, polyglyceryl-8 stearate or PPG-8 polyglyceryl-2 ether One or more selected from the group can be used in an amount of 80 to 99% by weight relative to the total weight of the anhydrous hydrophobic gel.
상기한 방법에 의해 제조된 본 발명의 복합안료는 콜라겐의 보습제로서의 역할 및 피부주름의 요철을 채우는 필링재로서의 역할을 더욱 향상시키기 위하여 무수 콜라겐이 함입된 무수 소수성 겔에 보습 바이오폴리머를 무수 소수성 겔 총 중량에 대하여 1∼20중량%의 양으로 더 함유시킬 수 있다.The composite pigment of the present invention prepared by the method described above is a hydrophobic gel containing an anhydrous hydrophobic gel in anhydrous hydrophobic gel containing anhydrous collagen to further enhance the role of the collagen as a moisturizing agent and a filler to fill the wrinkles of the skin wrinkles. It may be contained in an amount of 1 to 20% by weight based on the total weight.
보습 바이오폴리머는 보습효과를 갖는 바이오폴리머로서, 그 종류는 특별히 한정되지 않지만, 예를 들면, 아르기닌 DNA, 벤질히아루론산, 바이오사카라이드 검-1, 부톡시키토산, 칼슘 DNA, 카르복실부틸키토산, 카르복실메틸키틴, 카르복실메틸키토산숙신아미드, 키틴글리콜레이트, 구리 DNA, 디메틸실라놀히아루로네이트, DNA, 글리코겐, 글리코사미노글리칸, 히스티딘 DNA, 히아루론산, 수소화 벌꿀(hydrogenated honey), 리신 DNA, 마그네슘 DNA, 칼륨 DNA, 히아루론산칼륨, RNA, 소듐 콘드로이친 설페이트, 소듐 더마탄 설페이트(Sodium Dermatan Sulfate), 소듐 DNA, 소듐 헤파린(heparin), 소듐 히아루로네이트, 소듐 히아루로네이트 디메틸실라놀, 소듐 팔미토일 콘드로이친 설페이트, 소듐 RNA, 소듐 스테아로일 콘드로이친 설페이트, 소듐 스테아로일 DNA, 소듐 스테아로일 히아루로네이트, 수용성 프로티어글리칸(proteoglycan), 디메틸아미노에틸 에테르 스타치 또는 아연 DNA로 이루어진 군에서 선택된 1종 이상이다.The moisturizing biopolymer is a biopolymer having a moisturizing effect, and the kind thereof is not particularly limited. Examples thereof include arginine DNA, benzyl hyaluronic acid, biosaccharide gum-1, butoxychitosan, calcium DNA, carboxybutyl chitosan, and carbohydrate. Carboxymethyl chitin, carboxymethyl chitosan succinamide, chitin glycolate, copper DNA, dimethyl silanol hyaluronate, DNA, glycogen, glycosaminoglycan, histidine DNA, hyaluronic acid, hydrogenated honey, lysine DNA, Magnesium DNA, Potassium DNA, Potassium Hyaluronate, RNA, Sodium Chondroitin Sulfate, Sodium Dermatan Sulfate, Sodium DNA, Sodium Heparin, Sodium Hyaluronate, Sodium Hyaluronate Dimethylsilanol, Sodium Palmitoyl Chondroitin Sulfate, Sodium RNA, Sodium Stearoyl Chondroitin Sulfate, Sodium Stearoyl DNA, Sodium Stearoyl Hya At least one member selected from the group consisting of lauronate, water soluble proteoglycan, dimethylaminoethyl ether starch or zinc DNA.
무수 소수성 겔에 상기한 보습 바이오폴리머를 더 함유시키는 방법은, 콜라겐과 같이 보습 바이오폴리머를 오일에 고속분산시킨 후, 탈수·건조시켜 제조하거나, 탈수된 고형상의 보습 바이오폴리머를 콜라겐과 같이 1∼5㎛로 미분쇄한 후, 오일에 분산, 건조시키는 방법으로 함유시킬 수 있다.The method of further containing the above-mentioned moisturizing biopolymer in anhydrous hydrophobic gel is prepared by dispersing the moisturizing biopolymer in oil as high as collagen and then dehydrating and drying the same, or by dehydrating the solid moisturizing biopolymer as collagen. After pulverizing to -5 micrometers, it can contain by the method of disperse | distributing and drying in oil.
또한. 본 발명의 복합안료는, 상기 안료의 표면에 젯트-밀(Zet-Mill) 공법으로 분쇄한 초미립자 산화 아연을 더 부착시켜 알릴메타크릴레이트 가교중합체 파우더의 가루날림을 억제하고, 피부 부착력을 높이며, 자외선을 차단하여 피부를 보호할 수 있고, 우수한 피부 보정력을 제공할 수 있다.Also. The composite pigment of the present invention, by further adhering the ultrafine zinc oxide pulverized by the Jet-Mill method on the surface of the pigment to suppress the powder flying of the allyl methacrylate crosslinked polymer powder, to increase the skin adhesion, It can protect the skin by blocking UV rays and can provide excellent skin correction power.
즉, 3단 스크류 에어 노즐에서 형성된 고속 기류의 충격에 의하여 입자를 미세하게 분쇄하는 젯트 밀 공법을 이용하여 분쇄한 초미립자 산화 아연은 조대 입자 크기의 산화 아연보다 자외선 차단능력이 우수하다. 그리고, 산화 아연은 화장료의 백색안료로 많이 사용되는 산화 티탄보다 전자밴드의 간격(gap)이 크고 굴절률이 낮다. 따라서, 산화아연은 가시광선 영역에서는 투광률이 높아 자연스러운 피부색을 표현할 수 있고, 최근 피부암 유발의 요인으로 주목받고 있는 자외선 A영역(320∼400nm)을 효과적으로 차단할 수 있으며, 산화 티탄보다 분산력이 뛰어나 뭉침 현상이 적으므로, 이를 무수 소수성 겔이 함입된 알릴메타크릴레이트 가교중합체 파우더의 표면에 하이브리다아제이션 시스템을 이용한 정전기적 대전 현상으로 부착하여 상기한 효과를 얻을 수 있다.That is, the ultrafine zinc oxide pulverized using the jet mill method of finely pulverizing the particles by the impact of the high speed air flow formed by the three-stage screw air nozzle has better UV blocking ability than the zinc oxide having the coarse particle size. In addition, zinc oxide has a larger gap between electron bands and a lower refractive index than titanium oxide, which is often used as a white pigment for cosmetics. Therefore, zinc oxide has a high light transmittance in the visible light region and can express a natural skin color, and can effectively block ultraviolet ray A region (320-400 nm), which is recently attracting attention as a cause of skin cancer, and has excellent dispersibility than titanium oxide. Since the phenomenon is small, it can be attached to the surface of the allyl methacrylate crosslinked polymer powder containing anhydrous hydrophobic gel by an electrostatic charging phenomenon using a hybridization system to obtain the above-described effect.
상기한 본 발명의 복합안료는 화장료에 사용되는데 그 사용량은 그 제형에 따라 적당량으로 선정될 수 있으며, 바람직하게는 화장료 총 중량에 대하여 0.05∼70중량%의 양으로 함유된다.The complex pigment of the present invention is used in cosmetics, the amount of which may be selected in an appropriate amount according to the formulation, preferably contained in an amount of 0.05 to 70% by weight relative to the total weight of the cosmetic.
본 발명에 의한 복합안료를 함유한 화장료는 그 제형에 있어서 특별히 한정되는 바가 없으며, 예를 들면, 파우더 파운데이션, 크림 파운데이션, 메이크업베이스, 트윈케이크, 립스틱 등과 같은 제형을 가질 수 있다.Cosmetics containing a composite pigment according to the present invention is not particularly limited in the formulation, for example, may have a formulation such as powder foundation, cream foundation, makeup base, twin cake, lipstick and the like.
그리고, 각 제형의 화장료에 있어서, 상기한 복합안료 이외의 다른 성분들은 기타 화장료의 제형 또는 사용목적 등에 따라 당업자가 어려움없이 적의 선정하여 배합할 수 있다.In addition, in the cosmetics of each formulation, other components than the complex pigments described above can be appropriately selected and blended by those skilled in the art without difficulty according to the formulation or purpose of use of other cosmetics.
이하에서는 본 발명의 복합안료의 구체적인 제조예 및 시험예를 들어 본 발명을 보다 구체적으로 설명한다. 그러나, 본 발명이 이들예로만 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to specific preparation examples and test examples of the composite pigment of the present invention. However, the present invention is not limited only to these examples.
<참고예 1>Reference Example 1
<제조방법><Production method>
1) 성분 1을 24시간 동안 건조시켜 탈수시켰다.1) Component 1 was dried for 24 hours to dehydrate.
2) 상기 1)을 젯트-밀(Zet-Mill) 공법으로 분쇄하여 1㎛ 크기의 미세 입자로 분쇄하였다.2) The 1) was pulverized by the Jet-Mill process and pulverized into fine particles having a size of 1 μm.
3) 상기 2)를 성분 2에 혼합시킨 후, 고속 혼합하여 믹싱하였다.3) The above 2) was mixed with component 2, followed by high speed mixing.
4) 상기 3)를 24시간 건조, 탈수시켜 무수 소수성 겔을 얻었다.4) The above-mentioned 3) was dried and dehydrated for 24 hours to obtain anhydrous hydrophobic gel.
<참고예 2>Reference Example 2
<제조방법><Production method>
1) 성분 1과 성분 2를 24시간 동안 건조시켜 탈수시켰다.1) Components 1 and 2 were dried for 24 hours to dehydrate.
2) 상기 1)을 젯트-밀(Zet-Mill) 공법으로 분쇄하여 1㎛ 크기의 미세 입자로 분쇄하였다.2) The 1) was pulverized by the Jet-Mill process and pulverized into fine particles having a size of 1 μm.
3) 상기 2)를 성분 3에 혼합시킨 후, 고속 혼합하여 믹싱하였다.3) The above 2) was mixed with component 3, followed by high speed mixing.
4) 상기 3)를 24시간 건조, 탈수시켜 무수 소수성 겔을 얻었다.4) The above-mentioned 3) was dried and dehydrated for 24 hours to obtain anhydrous hydrophobic gel.
<참고예 3>Reference Example 3
<제조방법><Production method>
1) 성분 1과 성분 2를 성분 3에 혼합시킨 후, 고속 혼합하여 믹싱하였다.1) Component 1 and Component 2 were mixed with Component 3, followed by high speed mixing.
2) 상기 1)을 24시간 동안 건조시켜 무수 소수성 겔을 얻었다.2) The above 1) was dried for 24 hours to obtain anhydrous hydrophobic gel.
<참고예 4>Reference Example 4
<제조방법><Production method>
1) 성분 1과 성분 2를 성분 3에 고속 혼합하여 분산시켜 콜라겐 겔을 얻었다.1) Component 1 and Component 2 were mixed with Component 3 at high speed to obtain a collagen gel.
<시험예 1><Test Example 1>
상기에서 제조한 본 발명의 무수 소수성 겔(참고예 1내지 3)과 참고예 4의 콜라겐 겔의 팽윤정도를 비교하였다. 즉, 겔이 수분과 접촉한 전, 후의 부피증가를 체적계(Volumetary)로 측정하고, 그 결과를 표 1에 나타내었다.The swelling degree of the hydrophobic gel (Reference Examples 1 to 3) of the present invention prepared above and the collagen gel of Reference Example 4 were compared. That is, the volume increase before and after the gel contacted with water was measured by a volume meter, and the results are shown in Table 1.
상기 표 1로부터, 본 발명의 무수 소수성 겔(참고예 1 내지 3)은 팽윤효과가 크므로 피부의 결점이나 요철을 채워주는 필링재로서 효율적으로 작용할 수 있음을 알 수 있다.From Table 1, it can be seen that the anhydrous hydrophobic gel (Reference Examples 1 to 3) of the present invention has a great swelling effect and thus can effectively act as a peeling material to fill the defects and irregularities of the skin.
<제조예 1><Manufacture example 1>
<제조방법><Production method>
1) 성분 1을 성분 2에 분산시켰다.1) Component 1 was dispersed in component 2.
2) 성분 3을 성분 2에 분산시켰다.2) Component 3 was dispersed in component 2.
3) 상기 2)를 상기 1)에 가하여 혼합한 후 기계적으로 믹싱하였다.3) 2) was added to 1) above, followed by mixing, followed by mechanical mixing.
4) 상기 3)을 실온에서 24시간 동안 방치한 후, 에탄올을 증발시켰다.4) After leaving 3) at room temperature for 24 hours, ethanol was evaporated.
<제조예 2><Manufacture example 2>
<제조방법><Production method>
1) 성분 1을 성분 2에 분산시켰다.1) Component 1 was dispersed in component 2.
2) 성분 3을 성분 2에 분산시켰다.2) Component 3 was dispersed in component 2.
3) 상기 2)를 상기 1)에 가하여 혼합한 후 기계적으로 믹싱하였다.3) 2) was added to 1) above, followed by mixing, followed by mechanical mixing.
4) 상기 3)을 실온에서 24시간 동안 방치한 후 에탄올을 증발시켰다.4) After leaving 3) at room temperature for 24 hours, ethanol was evaporated.
5) 젯트 밀 공법으로 성분 4를 미세 분쇄하였다.5) Component 4 was finely ground by a jet mill method.
6) 하이브리다이져(Hybridizer)에 상기 4)와 상기 5)를 넣고 15분 동안 고속혼합하였다.6) 4) and 5) were added to a hybridizer and mixed at high speed for 15 minutes.
<제조예 3><Manufacture example 3>
<제조방법><Production method>
1) 성분 1을 성분 2에 분산시켰다.1) Component 1 was dispersed in component 2.
2) 성분 3을 성분 2에 분산시켰다.2) Component 3 was dispersed in component 2.
3) 상기 2)를 상기 1)에 가하여 혼합한 후 기계적으로 믹싱하였다.3) 2) was added to 1) above, followed by mixing, followed by mechanical mixing.
4) 상기 3)을 실온에서 24시간 동안 방치한 후, 에탄올을 증발시켰다.4) After leaving 3) at room temperature for 24 hours, ethanol was evaporated.
<비교제조예 1><Comparative Production Example 1>
<제조방법><Production method>
1) 성분 1을 성분 2에 분산시켰다.1) Component 1 was dispersed in component 2.
2) 성분 3을 성분 2에 분산시켰다.2) Component 3 was dispersed in component 2.
3) 상기 2)를 상기 1)에 가하여 혼합한 후 기계적으로 믹싱하였다.3) 2) was added to 1) above, followed by mixing, followed by mechanical mixing.
4) 상기 3)을 실온에서 24시간 동안 방치한 후, 에탄올을 증발시켰다.4) After leaving 3) at room temperature for 24 hours, ethanol was evaporated.
<시험예 2>보습효과 측정Test Example 2 Moisturizing Effect Measurement
각질층이 정상적인 기능을 하고 건강한 상태를 유지하기 위해서는 10∼20%의 수분을 함유할 필요가 있으며 각질층의 수분량이 감소하면 유연성을 잃어 딱딱하게 된다. 그러므로, 파우더의 비차별화된 수분 흡수로 인한 피부의 건조함이나 당김 현상없이 피부의 수분을 일정량 유지시켜 주는 효과를 측정하기 위하여 각질층의 수분량을 측정하였다.In order for the stratum corneum to function properly and maintain a healthy state, it needs to contain 10 to 20% of moisture, and when the amount of moisture in the stratum corneum decreases, it loses its flexibility and becomes hard. Therefore, the moisture content of the stratum corneum was measured to measure the effect of maintaining a certain amount of moisture in the skin without drying or pulling the skin due to the non-differentiated moisture absorption of the powder.
즉, 상기 제조예 1 내지 3 및 비교제조예 1의 복합안료 0.01g씩을 5cm x 5cm 정사각형 면적의 피부위에 고르게 도포한 후에, 1시간이 경과한 후, 에어프레셔로 시료를 제거하고 코르네오메타(Corneometer) CM820으로 수분 변화량을 측정하여 그 결과를 표 2에 나타내었다.That is, after 0.01 g of each of the composite pigments of Preparation Examples 1 to 3 and Comparative Production Example 1 were evenly applied on the skin of a 5 cm x 5 cm square area, after 1 hour, the sample was removed by air pressure and the corneo meta ( Corneometer) The moisture change was measured with CM820 and the results are shown in Table 2.
상기 표 2로부터, 효모 다당체 분말에 콜라겐을 함입시킨 비교제조예 1의 안료는 본 발명의 안료보다 피부의 수분 함량의 변화가 크다는 것을 알 수 있다. 따라서, 콜라겐이나 콜라겐과 보습 바이오폴리머를 함유하는 무수 소수성 겔을 함유하는 경우 비차별적인 유, 수분의 흡수가 일어나지 않고, 피부의 수분을 유지시켜 건조하거나 당기는 현상을 막아 줄 수 있다.From Table 2, it can be seen that the pigment of Comparative Preparation Example 1 in which collagen is incorporated into the yeast polysaccharide powder has a larger change in moisture content of the skin than the pigment of the present invention. Therefore, in the case of containing anhydrous hydrophobic gel containing collagen or collagen and a moisturizing biopolymer, non-differentiated absorption of oil and water does not occur, and it is possible to prevent the phenomenon of drying or pulling by maintaining moisture of the skin.
<시험예 3><Test Example 3>
무수 소수성 겔속에 함유된 콜라겐 또는 콜라겐과 보습 바이오폴리머에 의한 피부요철의 필링효과를 확인하기 위하여 제조예 1 내지 3 및 비교제조예 1의 복합안료가 수분과 접촉한 후에 팽윤되는 정도를 측정하였다. 즉, 수분 접촉 전 후의 부피증가를 체적계(Volumetary)로 측정하고, 그 결과를 표 3에 나타내었다.In order to confirm the peeling effect of collagen or collagen contained in the hydrophobic hydrogel and the moisturizing biopolymer, the composite pigments of Preparation Examples 1 to 3 and Comparative Preparation Example 1 were measured to swell after contact with water. That is, the volume increase before and after contact with water was measured by a volume meter, and the results are shown in Table 3.
상기 표 3으로부터, 무수 소수성 겔을 함유하는 제조예 2와 3의 복합안료는 피부 각질층의 수분에 의해서 무수 아텔로콜라겐과 소듐 콘드로이친 설페이트가 팽윤되므로, 피부의 결점이나 요철을 채워주는 필링재로서 작용할 수 있음을 알 수 있다. 아울러, 아텔로콜라겐이 단독으로 함유된 무수 소수성 겔을 함유하는 제조예 1의 복합안료는 소듐 콘드로이친 설페이트와 같이 함유되는 복합안료보다 필링재로서의 효과는 미흡하나, 아텔로콜라겐을 효모 다당체 분말에 함입시킨 복합안료보다는 그 효과가 우수함을 알 수 있다.From Table 3, the composite pigment of Preparation Examples 2 and 3 containing anhydrous hydrophobic gel swells anhydrous atelocollagen and sodium chondroitin sulfate by moisture in the stratum corneum, thus acting as a peeling material to fill skin defects and irregularities. It can be seen that. In addition, the composite pigment of Preparation Example 1 containing anhydrous hydrophobic gel containing atelocollagen alone had less effect as a filler than the composite pigment contained with sodium chondroitin sulfate, but incorporating atelocollagen into yeast polysaccharide powder. It can be seen that the effect is superior to the composite pigment.
<시험예 4>피부 밀착감(Skin affinity) 측정Test Example 4 Measurement of Skin Affinity
상기에서 제조한 복합안료는 화장료용 안료로서 사용하기 위한 것으로, 주로 최종 마무리용으로 사용되어 진다. 따라서, 실제 피부의 조건과 유사한 조건을 만들기 위해서 어플리케이터를 가지고 리퀴드 파운데이션을 유리판 위에 도포한 후, 12시간이 경과하면 퍼프를 가지고 복합안료를 5g 취하고, 유리판 위의 리퀴드 파운데이션과 7회 접촉을 실시하여 유리판의 무게 변화를 측정하였다. 다시 위의 실험을 5회 실시하여 최고와 최저의 수치를 제하고 나머지 3번의 실험의 평균을 구하여, 그 결과를 표 4에 나타내었다.The composite pigment prepared above is for use as a pigment for cosmetics, and is mainly used for final finishing. Therefore, in order to make the condition similar to the actual skin condition, apply liquid foundation on the glass plate with the applicator, and after 12 hours, take 5g of the composite pigment with puff, and make 7 times contact with the liquid foundation on the glass plate. The weight change of the glass plate was measured. Again, the above experiment was carried out five times to remove the highest and lowest values and to average the remaining three experiments. The results are shown in Table 4.
상기 표 4로부터, 효모 다당체 분말에 콜라겐을 함입시킨 비교제조예 1의 안료는 피부와의 밀착감이 매우 낮음을 알 수 있다.From Table 4, it can be seen that the pigment of Comparative Preparation Example 1 in which collagen is incorporated into the yeast polysaccharide powder has very low adhesion to skin.
<시험예 5>자외선 차단 시험<Test Example 5> UV blocking test
무수 소수성 겔을 알릴메타크릴레이트 가교중합체 파우더에 함입시킨 본 발명의 복합안료의 표면에 초미립자 산화아연을 부착시킨 경우 자외선 차단효과를 부가적으로 얻을 수 있다. 따라서, 초미립자 산화아연을 부착한 제조예 2의 복합안료와 부착하지 않은 제조예 3의 복합안료의 광학적인 특성을 알아보기 위하여 UV / Vis 스펙트럼을 측정하였다. 측정방법은 폴리비닐피롤리돈을 LC Reagent 등급의 메탄올에 1:10 무게 비율로 용해시켜 만든 필름 형성제와 제조예 1과 2의 복합안료를 혼합, 분산시킨 후, 100㎛ 필름 어플리케이터를 사용하여 석영판위에 도포한 후 320∼800nm영역에서 투광도를 측정하였다. 그 결과는 도 1과 같다.When the ultrafine particle zinc oxide is attached to the surface of the composite pigment of the present invention in which the anhydrous hydrophobic gel is incorporated into the allyl methacrylate crosslinked polymer powder, an ultraviolet ray blocking effect can be additionally obtained. Therefore, UV / Vis spectrum was measured to investigate the optical properties of the composite pigment of Preparation Example 2 with ultrafine zinc oxide attached and the composite pigment of Preparation Example 3 without. The measuring method was a film forming agent made by dissolving polyvinylpyrrolidone in 1:10 weight ratio of LC Reagent methanol and the composite pigment of Preparation Examples 1 and 2, followed by dispersing, using a 100 μm film applicator. After coating on the quartz plate, the light transmittance was measured in the range of 320 to 800 nm. The result is shown in FIG.
도 1로부터, 제조예 2와 3의 복합안료 모두 가시광선 영역에서는 투광도가 높지만, 제조예 2의 안료는 제조예 3의 안료에 비하여 자외선 영역에서 투광도가 낮다는 것을 알 수 있다. 즉, 제조예 2의 안료가 가시광선 영역에서는 피부색을 자연스럽게 표현해 주고 자외선영역에서는 피부암 유발의 주된 원인인 자외선 A를 차단해줄 수 있다는 것을 알 수 있다. 따라서, 무수 소수성 겔이 합입된 알릴메타크릴레이트 가교중합체 파우더의 표면에 초미립자 산화아연을 부착하는 경우 자외선을 차단시켜 피부를 보호할 수 있다.1, it can be seen that the composite pigments of Preparation Examples 2 and 3 have high light transmittance in the visible region, but the pigment of Preparation Example 2 has a lower transmittance in the ultraviolet region than the pigment of Preparation Example 3. In other words, it can be seen that the pigment of Preparation Example 2 naturally expresses the skin color in the visible light region and blocks UV-A, which is the main cause of skin cancer in the ultraviolet light region. Therefore, when ultrafine zinc oxide adheres to the surface of the allyl methacrylate crosslinked polymer powder in which anhydrous hydrophobic gel is incorporated, ultraviolet rays may be blocked to protect the skin.
<시험예 6>소프트-포커싱(Soft-Focusing) 효과 측정Test Example 6 Measurement of Soft-Focusing Effect
피부의 주름이 눈에 보이는 주된 이유는 피부의 평탄한 부분은 빛을 반사시켜 밝게 보이는 반면, 피부의 들어간 부분에서는 빛을 반사시키지 못하여 어둡게 보이기 때문에, 광학적인 분산체의 주된 목적은 빛이 피부의 들어간 부분에 트래핑되어 반사시키지 못하는 것을 막아 주는 것이다. 따라서 색상차에 의해서 피부의 결점을 가려주는 것이 아니라 자연스런 자신의 피부색을 표현해 주면서 피부의 들어간 부분과 나온 부분의 명도차를 최소화시켜 주는 것이 소프트-포커싱 효과를 극대화시키는 것이라고 할 수 있다. 따라서, 상기 제조예 2과 3의 복합안료의 화장막 도포전과 도포후의 피부의 명도차를 색도측정계(Colormeter; Spectrogard II)를 이용하여 측정하고, 그 결과를 표 5에 나타내었다.The main reason for the appearance of wrinkles on the skin is that the flat areas of the skin reflect light and appear bright while the indented areas of the skin do not reflect light and appear dark. It traps the part and prevents it from reflecting. Therefore, it is possible to maximize the soft-focusing effect by minimizing the difference in brightness between the in and out parts of the skin while expressing the natural color of the skin, rather than masking the flaws of the skin by the color difference. Therefore, the difference in the brightness of the skin before and after applying the makeup film of the composite pigments of Preparation Examples 2 and 3 was measured using a colorimeter (Spectrogard II), and the results are shown in Table 5.
상기 표 5로부터, 제조예 2의 복합안료가 제조예 3의 안료에 비하여 명도차가 크므로 소프트-포커싱 효과가 우수하다는 것을 알 수 있다. 따라서, 초미립자 산화아연을 부착한 복합안료는 자신의 피부색을 자연스럽게 표현해 주면서 결점을 가려줄 수 있으므로, 피부의 보정능력이 우수하다.From Table 5, it can be seen that the composite pigment of Preparation Example 2 is excellent in soft-focusing effect because the brightness difference is larger than the pigment of Preparation Example 3. Therefore, the composite pigment attached with ultrafine zinc oxide can mask the defects while expressing the natural color of the skin, so the skin's correction ability is excellent.
이하, 제조예 1 내지 3, 비교제조예 1에서 제조된 복합안료들을 화장료(표 6과 표 8)에 투입한 후, 20대 초반부터 40대 중반까지의 전문판넬 요원 200명에게 연령대별로 구분하여 4주일 동안 사용하게 한 후, 가루날림, 밀착감, 피부표현력, 사용감, 보습감, 피부 보정력을 10점 만점으로 평가하게 하였다. 그리고, 각 연령대별 평균점을 표 6과 표 8에 나타내었다.Hereinafter, the composite pigments prepared in Preparation Examples 1 to 3 and Comparative Production Example 1 were added to cosmetics (Tables 6 and 8), and then divided into 200 professional panel agents from the early 20s to the mid 40s by age group. After four weeks of use, the powdery, fit, skin expression, feeling, moisturizing, skin correction power was evaluated by a perfect score of 10 points. And the average score for each age group is shown in Table 6 and Table 8.
<제조방법><Production method>
1) 성분 1∼9를 헴머타입의 분쇄기로 1회 분쇄하였다.1) The components 1-9 were grind | pulverized once with the hemmer type grinder.
2) 상기 1)을 고속혼합기에 넣고 5분동안 고속혼합하였다.2) The above 1) was put into a high speed mixer and mixed for 5 minutes at high speed.
3) 상기 2)에 성분 10∼13을 혼합 가열하여 분무 투입하였다.3) The components 10-13 were mixed and heated in 2) and spray-injected.
4) 상기 3)을 고속혼합기로 5분동안 고속혼합하였다.4) The above 3) was mixed at high speed for 5 minutes by a high speed mixer.
5) 상기 4)를 헴머타입의 분쇄기로 5분동안 분쇄하였다.5) The above 4) was ground for 5 minutes with a hemmer type grinder.
<제조방법><Production method>
1) 성분 1∼6을 95℃까지 가열하면서 균질혼합(Homogeneous Mixing)하였다.1) Homogeneous Mixing was carried out while heating components 1 to 6 to 95 ° C.
2) 상기 1)에 성분 7∼12을 각각 넣고 균질혼합하였다.2) The components 7-12 were put into 1), and it mixed homogeneously.
3) 상기 2)에 성분 13를 넣고 균질혼합하였다.3) Component 13 was added to 2) and homogeneously mixed.
4) 성분 14∼17을 85℃까지 가열하면서 균질혼합하였다.4) The components 14-17 were homogeneously mixed while heating to 85 degreeC.
5) 상기 4)에 상기 3)을 가한 후 균질혼합하였다.5) Add 3) to 4) and homogeneously mix.
6) 상기 5)를 균질혼합하면서 냉각시켰다.6) The above 5) was cooled while homogeneously mixing.
상기 표 7과 표 9로부터 알 수 있는 바와 같이, 본 발명의 복합안료는 화장료에 함유되어 가루날림, 밀착감, 피부표현력, 사용감, 보습감, 피부 보정력 측면에서 모두 우수한 효과를 나타낸다.As can be seen from Table 7 and Table 9, the composite pigment of the present invention is contained in the cosmetics exhibits excellent effects in terms of powderiness, adhesion, skin expression, usability, moisturizing, skin correction power.
상기에서 설명한 바와 같이, 콜라겐이나, 콜라겐과 보습 바이오폴리머를 함유하는 무수 소수성 겔을 알릴메타크릴레이트 가교중합체 파우더에 함입시킨 본 발명의 복합안료는 피부수분의 균형을 유지해주어 피부와 화장막의 갈라짐을 방지할 수 있고, 피부와의 밀착력이 우수하며, 주름이 두드러지는 것을 방지하는데 효과적이다. 더구나, 상기 안료의 표면에 초미립자 산화아연을 더 부착한 복합안료는 자외선을 차단하여 피부를 보호해주면서, 뭉침현상 없이 제형내에 고르게 분포하고, 자신의 피부색을 자연스럽게 표현해주면서 결점을 자연스럽게 가려줄 수 있는 피부보정 능력이 우수하다. 따라서, 본 발명의 복합안료를 함유하는 화장료는 상기한 효과를 제공하는데 효과적이다.As described above, the composite pigment of the present invention incorporating collagen or anhydrous hydrophobic gel containing collagen and a moisturizing biopolymer into allyl methacrylate crosspolymer powder maintains the balance of skin moisture and prevents cracking of the skin and the cosmetic film. It can prevent, excellent adhesion to skin, and effective in preventing wrinkles from becoming noticeable. In addition, the composite pigment is further attached to the surface of the pigment ultrafine zinc oxide to protect the skin by blocking ultraviolet rays, evenly distributed in the formulation without agglomeration phenomenon, to express the natural color of their skin while naturally masking the defects Excellent correction ability Therefore, the cosmetic containing the composite pigment of the present invention is effective in providing the above-mentioned effect.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019990010994A KR100285396B1 (en) | 1999-03-30 | 1999-03-30 | A composite powder, a method for preparing of the same and make-up cosmetics containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019990010994A KR100285396B1 (en) | 1999-03-30 | 1999-03-30 | A composite powder, a method for preparing of the same and make-up cosmetics containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20000061722A KR20000061722A (en) | 2000-10-25 |
| KR100285396B1 true KR100285396B1 (en) | 2001-03-15 |
Family
ID=19578193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019990010994A KR100285396B1 (en) | 1999-03-30 | 1999-03-30 | A composite powder, a method for preparing of the same and make-up cosmetics containing the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100285396B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030041738A (en) * | 2001-11-21 | 2003-05-27 | 주식회사 랩인베스트어소시에이츠 | Cosmetic composition containing lysine added succinate or sulfonated atelocollagen and hyaluronic acid as essential ingredients |
| CN116270289A (en) * | 2023-02-03 | 2023-06-23 | 完美（广东）日用品有限公司 | Ionic gel composition containing hydrolyzed actin and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101139328B1 (en) * | 2009-08-04 | 2012-04-26 | 주식회사 피오 코리아 | Cosmetic Composition for Skin-aging Protection |
-
1999
- 1999-03-30 KR KR1019990010994A patent/KR100285396B1/en not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030041738A (en) * | 2001-11-21 | 2003-05-27 | 주식회사 랩인베스트어소시에이츠 | Cosmetic composition containing lysine added succinate or sulfonated atelocollagen and hyaluronic acid as essential ingredients |
| CN116270289A (en) * | 2023-02-03 | 2023-06-23 | 完美（广东）日用品有限公司 | Ionic gel composition containing hydrolyzed actin and preparation method thereof |
| CN116270289B (en) * | 2023-02-03 | 2023-08-29 | 完美（广东）日用品有限公司 | Ionic gel composition containing hydrolyzed actin and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000061722A (en) | 2000-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9822243B2 (en) | Freeze-dried composition | |
| US9056053B2 (en) | Nanoparticle compositions providing enhanced color for cosmetic formulations | |
| US8986667B2 (en) | Cosmetic composition with skin tightening effect | |
| KR101191268B1 (en) | Capsule composition contained nano inorganic particles for sunscreen product by hydrogel-forming polymers and manufacturing method thereof | |
| TWI468185B (en) | Gel technology suitable for use in cosmetic compositions | |
| US5024831A (en) | Powdery cosmetic containing cellulose powder impregnated with moisturizing polymer | |
| TW200927186A (en) | Optical blurring pigment composition suitable for use in cosmetics | |
| MXPA05005134A (en) | Cosmetic dressings containing a waxy component, a film-forming agent and a gel-forming substance. | |
| ES2607930T3 (en) | Agent to improve fine wrinkles | |
| KR100285396B1 (en) | A composite powder, a method for preparing of the same and make-up cosmetics containing the same | |
| KR101630825B1 (en) | Cosmetic composition with excellent durability and manufacturing method thereof | |
| KR20210017476A (en) | A freeze-dried formulation composition and a skin external application cosmetic kit comprising the same | |
| RU2662068C2 (en) | Pigmented skin-care compositions | |
| RU2662073C2 (en) | Pigmented skin-care compositions | |
| JP2762574B2 (en) | Composite particles | |
| KR101978370B1 (en) | Cosmetic composition with excellent durability and manufacturing method thereof | |
| KR20110073935A (en) | Cosmetic compositions containing adipic acid neophentyl glicol crosspolymer suspension solution for covering the skin pores | |
| JP2611956B2 (en) | Skin cosmetics | |
| JP2004307434A (en) | Water-resistant o/w emulsion composition and water-resistant o/w cosmetic having ultraviolet prevention effect and containing water-resistant o/w emulsion composition therein | |
| JP2553474B2 (en) | Skin cosmetics | |
| KR100449925B1 (en) | Liquid Ingredient-Containing Cosmetic Composition in a Form of Powder Comprising Ascorbic Acid 2-Glucose | |
| KR20230137320A (en) | Calcium hydroxyapatite particles and uses thereof | |
| KR20230116300A (en) | Cosmetic composition using low molecular weight poly glutamic acid | |
| KR20210137765A (en) | Powder formulation cosmetic composition | |
| KR0182400B1 (en) | Method for preparation of composite pigment for cosmetics and cosmetic compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20061227 Year of fee payment: 8 |
|
| LAPS | Lapse due to unpaid annual fee |